| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |